Ftse Mib
35.108,74
0,49%
DAX
20.329,94
-0,10%
S&P 500
5.918,25
0,16%
NASDAQ
19.478,88
-0,06%
Bitcoin
94.982,02
-0,07%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ProQR Therapeutics NV (PRQR) ProQR Therapeutics NV (PRQR) Notizie

PRQR

ProQR Therapeutics NV (PRQR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRQR
DataOraFonteTitoloSimboloCompagnia
12/12/202414:22Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:PRQRProQR Therapeutics NV
11/12/202422:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
24/10/202412:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRQRProQR Therapeutics NV
11/10/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRQRProQR Therapeutics NV
30/09/202423:05Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PRQRProQR Therapeutics NV
14/02/202412:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
14/09/202323:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
16/05/202313:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
25/04/202312:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
24/04/202322:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
29/03/202322:55Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
29/03/202322:54Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
29/03/202322:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
14/02/202316:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
10/11/202212:35TipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
09/11/202221:40TipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
12/08/202203:15TipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
11/08/202214:37TipRanksProQR (PRQR) was downgraded to a Hold Rating at JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
05/08/202212:38TipRanksH.C. Wainwright Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
05/08/202200:35TipRanksChardan Capital Reaffirms Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
04/08/202223:25TipRanksJMP Securities Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
09/05/202204:35TipRanksProQR (PRQR) Gets a Hold Rating from Stifel NicolausNASDAQ:PRQRProQR Therapeutics NV
06/05/202213:46TipRanksChardan Capital Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
06/05/202206:55TipRanksJMP Securities Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202213:25TipRanksChardan Capital Remains a Buy on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202206:25TipRanksJMP Securities Reiterates Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
09/02/202216:27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRQRProQR Therapeutics NV
04/02/202215:13Edgar (US Regulatory)Schedule 13gNASDAQ:PRQRProQR Therapeutics NV
20/01/202206:25TipRanksJMP Securities Keeps Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
16/12/202122:15TipRanksProQR (PRQR) Gets a Buy Rating from JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRQR

La tua Cronologia

TG
XS6R
Deutsche Bank Luxembourg
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network